ADEPT 9:Enhancing Diversity in Therapeutics Development for Pediatric Patients (Session 2)

ADEPT 9:Enhancing Diversity in Therapeutics Development for Pediatric Patients (Session 2)

Dana Hammell

54 года назад

60 Просмотров

The purpose of the workshop was to solicit input from stakeholders on increasing the enrollment of historically underrepresented population in pediatric clinical studies, and to encourage pediatric clinical study participation that reflects the prevalence of the other disease or condition among demographic subgroups, where appropriate and other topics.

Session 2: Inclusion Strategies
Inclusive Trial Designs and Methodological Considerations (Case Examples)
Recruitment and Retention/Decentralized Trials-Rachel Randell
Addressing Diversity in Clinical Trials and Diversity Plans-Ted Love and Bella Oguno
Diversity in Pediatric Type 2 Diabetes Trials-Lauren Wood Heickman
Panel Discussion

Panel Discussion: Community Engagement and Trust Building

Best Practices That Help Children and Families to Stay in Clinical Trials-
Tamorah Lewis
Christina Edwards
Puja Umaretiya
Panel Discussion
Closing Remarks-Lynne Yao
Ссылки и html тэги не поддерживаются


Комментарии: